硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 N-terminal Tau 抗体对
试剂盒

人 N-terminal Tau 抗体对

01AB03488

N-terminal Tau refers to specific truncated fragments of the tau protein that retain the N-terminal projection domain while lacking C-terminal microtubule-binding regions. These fragments, often terminating near residue 224, are actively secreted by neurons in response to amyloid-beta-induced stress and synaptic dysfunction. Biochemically, they represent the dominant forms of tau circulating in plasma and cerebrospinal fluid due to the rapid degradation of C-terminal regions in blood. Clinically, this marker is emerging as a robust indicator of Alzheimer's disease progression, functioning as a dual marker for both neurofibrillary tangle load and neurodegeneration. It demonstrates high concordance with tau-PET imaging and offers predictive value for cognitive decline and brain atrophy comparable to or exceeding other neurodegeneration markers.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
MAPT
基因别名
MAPTL; MTBT1; TAU
蛋白别名
Microtubule-associated protein tau; N-terminal Tau
UniProt
P10636-8
物种
Human

产品详情

靶点名称
N-terminal Tau
蛋白名称
Microtubule-associated protein tau
靶点基因名
MAPT
基因别名
MAPTL; MTBT1; TAU
UniProt
P10636-8
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

N-terminal Tau refers to specific truncated fragments of the tau protein that retain the N-terminal projection domain while lacking C-terminal microtubule-binding regions. These fragments, often terminating near residue 224, are actively secreted by neurons in response to amyloid-beta-induced stress and synaptic dysfunction. Biochemically, they represent the dominant forms of tau circulating in plasma and cerebrospinal fluid due to the rapid degradation of C-terminal regions in blood. Clinically, this marker is emerging as a robust indicator of Alzheimer's disease progression, functioning as a dual marker for both neurofibrillary tangle load and neurodegeneration. It demonstrates high concordance with tau-PET imaging and offers predictive value for cognitive decline and brain atrophy comparable to or exceeding other neurodegeneration markers.